Company news
Kintor Pharmaceutical Ltd news in 2026
Kintor Pharmaceutical Ltd's news releases, calls and decks from 2026, newest first.
Voluntary announcement - completion of long-term safety clinical trial of KX-826 tincture 1.0% for the treatment of male adult AGA in China
November 2, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 2, 2026
Update on measures and actions taken in resolving the disclaimer of opinion in the annual report for the year ended 31 December 2025
October 30, 2026
Voluntary announcement - receipt of notice of grant of invention patent for KT-939
October 21, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 2, 2026
Interim report 2026
September 29, 2026
Resignation of chief financial officer, joint company secretary and process agent, appointment of chief financial officer and appointment of process agent
September 21, 2026